Marketbeat

Published October 21, 2026

Cybin Eyes Q4 Phase III Depression Data as Anxiety Program Advances - MarketBeat

Read the full story at Marketbeat

Image from MarketBeat Media, LLC. Magic Mushrooms , Hard Cash: Compass Pathways' Trial Win, Fast Raise · Cybin NASDAQ: HELP outlined plans for two.